China Universal Fund reduces its holdings in Keymed Biosciences (02162) by 991,000 shares at approximately HK$70.9 per share.
On October 27, China Universal Fund Management Co., Ltd. reduced its holdings of Keymed Biosciences (02162) by 991,000 shares at HK$70.8951 per share, for a total amount of approximately HK$70.257 million.
The latest data from the Hong Kong Stock Exchange shows that on October 27, China Universal Fund Management Co., Ltd. reduced its holdings in Keymed Biosciences (02162) by 991,000 shares at HK$70.8951 per share, for a total amount of approximately HK$70.257 million. Following the reduction, its latest shareholding is approximately 14,197,500 shares, with its latest shareholding percentage at 4.75%.
Related Articles
NIO (09866) delivered 334,547 vehicles from January to October; its market share in the battery-electric large SUV segment exceeded 70% in the first three quarters.
Guosen Textile and Apparel Q3 Earnings Summary: Divergence at the Brand End Widens Further; Manufacturing Shows "Midstream Recovery, Upstream Price Hikes"
CICC comments on October PMI data: PMI decline mainly affected by seasonal factors; drop exceeding average reflects marginal weakening of demand.
NIO (09866) delivered 334,547 vehicles from January to October; its market share in the battery-electric large SUV segment exceeded 70% in the first three quarters.
Guosen Textile and Apparel Q3 Earnings Summary: Divergence at the Brand End Widens Further; Manufacturing Shows "Midstream Recovery, Upstream Price Hikes"
CICC comments on October PMI data: PMI decline mainly affected by seasonal factors; drop exceeding average reflects marginal weakening of demand.
